Relay Therapeutics, Inc.
RLAY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$74,149 | -$70,375 | -$77,065 | -$76,004 |
| Dep. & Amort. | $748 | -$392 | -$389 | $1,334 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $14,500 | $19,325 | $0 |
| Change in WC | -$3,497 | -$1,909 | -$15,081 | $1,449 |
| Other Non-Cash | $14,779 | $2,915 | $0 | $15,353 |
| Operating Cash Flow | -$62,119 | -$55,261 | -$73,210 | -$57,868 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $1 | -$26 | -$384 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$58,076 | -$8,928 | -$21,971 | -$75,076 |
| Inv. Sales/Matur. | $97,800 | $84,100 | $64,820 | $104,074 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $39,725 | $75,146 | $42,465 | $28,998 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $17 | $0 | $0 | $800 |
| Stock Repurch. | $0 | $653 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $17 | $653 | $0 | $800 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$22,377 | $20,538 | -$30,745 | -$28,070 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $113,941 | $95,661 | $126,406 | $152,357 |
| End Cash | $91,564 | $116,199 | $95,661 | $124,287 |
| Free Cash Flow | -$62,118 | -$55,287 | -$73,594 | -$57,868 |